期刊文献+

慢性粒细胞白血病骨髓间充质干细胞的分离及其支持造血的研究 被引量:4

Isolation and characterization of chronic myelogenous leukemia bone marrow mesenchymal stem cells and their hematopoiesis support ability
原文传递
导出
摘要 目的探讨慢性粒细胞白血病(CML)患者骨髓间充质干细胞(MSCs)的分离以及体外支持造血的能力。方法采用细胞贴壁法获取16例CML患者的骨髓MSCs,在低血清培养液中培养和扩增。流式细胞仪检测免疫表型。通过油红O染色和Von Kossa染色检测MSCs向脂肪和骨的分化。逆转录聚合酶链法(RT-PCR)检测bcr/ahl融合基因的表达。对MSCs进行核型分析。RT PCR检测细胞因子表达情况。将CML患者的骨髓MSCs作为滋养层,应用甲基纤维素半固体培养,检测其支持造血能力。结果CML来源的MSCs在倒置显微镜下为梭形,表达CD29、CD44、CD105,而CD14,CD31、CD34、CD45、HLA-DR均为阴性。在相应的诱导条件下可以向骨和脂肪分化。CML来源的MSCs不表达bcr/abl融合基因,具有正常细胞核型。CML来源的MSCs表达造血相关因子,在体外可以维持和扩增造血干/祖细胞。结论CML患者骨髓中存在具有多向分化能力的MSCs,其具有在体外支持造血的功能。 Objective To study the characteristics o f-mesenchymal stem cells (MSCs) derived from chronic myelogenous leukemia (CML) patients" bone marrow and examine their hematopoiesis support in vitro. Methods MSCs from CML were obtained and cultured. Immunophenotype and in vitro differentiation capacities were investigated. Moreover, the Ph chromosome and bcr/abl gene of CML derived MSCs were detected. The expression of cytokines was detected by RT-PCR, and hematopoiesis support of MSCs in vitro was detected by long-term bone marrow culture and the methylcellulose progenitor assay. Results CML derived MSCs showed a typical fibroblast like morphology. They were positive for CD29, CD44 and CD105, while negative for CD14, CD31, CD45, CD34 and HLA-DR. Under suitable conditions, CML derived MSCs could differentiate into osteoblasts and adipocytes. Further, CML derived MSCs showed a normal choromosome, and did not express bcr/abl gene. At last, they expressed hematopoiesis cytokines and possessed ability of hematopoiesis support in vitro. Conclusion There are MSCs with multidirectional differentiation potential in CML bone marrow and they possess the ability of hematopoiesis support.
出处 《中华器官移植杂志》 CAS CSCD 北大核心 2006年第10期623-626,共4页 Chinese Journal of Organ Transplantation
关键词 白血病 髓样 慢性 间质干细胞 造血系统 Leukemia, myelogenous, chronic Mesenchymal stem cells Hematopoiesis system
  • 相关文献

参考文献10

  • 1Reyes M,Lund T,Lenvik T,et al.Purification and ex vivo ex pansion of postnatal human marrow mesodermal progenitor cells.Blood,2001,98:2615-2625. 被引量:1
  • 2Noort WA,Kruisselbrink AB,in't Anker PS,et al.Mesenchy mal stem cells promote engraftment of human umbilical cord blood-derived CD34 (+) cells in NOD/SCID mice.Exp Hematol,2002,30:870-878. 被引量:1
  • 3Koc ON,Gerson SL,Cooper BW,et al.Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy.J Clin Oncol,2000,18:307-316. 被引量:1
  • 4张之南主编..血液病诊断及疗效标准 第2版[M].北京:科学出版社,1998:434.
  • 5Rowley JD.A new consistent chromosome abnormality in chron ic myelogenous leukemia.Nature,1973,243:290-293. 被引量:1
  • 6de Klein A,van Kessel AG,Grosveld G,et al.A cellular oncogene is translocated to the philadelphia chromosome in chronic myelocytic leukemia.Nature,1982,23:765-767. 被引量:1
  • 7Cilloni D,Carlo-Stella C,Falzetti F,et al.Limited engraftment capacity of bone marrow derived mesenchymal cells following Tcell depleted hematopoietic stem cell transplantation.Blood,2000,96:3637-3643. 被引量:1
  • 8Koc ON,Day J,Nieder M,et al.Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPSIH).Bone Marrow Trans plantation,2002,30:215-222. 被引量:1
  • 9Devine SM,Bartholomew AM,Mahmud N,et al.Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion.Exp Hematol,2001,29:244-255. 被引量:1
  • 10Lazarus HM,Hayncsworth SE,Gerson SL,et al.Ex vivo ex pansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells):impli cations for therapeutic use.Bone Marrow Transplant,1995,16:557-564. 被引量:1

同被引文献31

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部